down arrow

Beijing Balance Medical Technology Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100005X15
CNY
118.21
-1.15 (-0.96%)

Dec 04

SHG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Beijing Balance Medical Technology Co., Ltd.
Why is Beijing Balance Medical Technology Co., Ltd. ?
1
  • NET SALES(Q) At CNY 98.8 MM has Fallen at -20.6%
  • DEBT-EQUITY RATIO (HY) Highest at -15.44 %
  • CASH AND EQV(HY) Lowest at CNY 608.3 MM
2
With ROE of 13.89%, it has a expensive valuation with a 11.79 Price to Book Value
  • Over the past year, while the stock has generated a return of -0.43%, its profits have risen by 79.2% ; the PEG ratio of the company is 1.1
  • At the current price, the company has a high dividend yield of 0.8
3
Underperformed the market in the last 1 year
  • Even though the market (China Shanghai Composite) has generated returns of 14.77% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -0.43% returns
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Beijing Balance Medical Technology Co., Ltd. for you?

Medium Risk, Low Return

Absolute
Risk Adjusted
Volatility
Beijing Balance Medical Technology Co., Ltd.
-0.43%
0.28
34.13%
China Shanghai Composite
14.77%
1.01
14.58%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
30.99%
EBIT Growth (5y)
21.12%
EBIT to Interest (avg)
79.77
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.16
Sales to Capital Employed (avg)
0.34
Tax Ratio
12.30%
Dividend Payout Ratio
75.12%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
17.39%
ROE (avg)
8.11%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
85
Industry P/E
Price to Book Value
11.79
EV to EBIT
84.85
EV to EBITDA
72.41
EV to Capital Employed
14.49
EV to Sales
25.55
PEG Ratio
1.07
Dividend Yield
0.76%
ROCE (Latest)
17.07%
ROE (Latest)
13.89%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

21What is working for the Company
NET SALES(HY)

At CNY 306.54 MM has Grown at 62.64%

OPERATING CASH FLOW(Y)

Highest at CNY 164.12 MM

NET PROFIT(HY)

Higher at CNY 119.62 MM

ROCE(HY)

Highest at 13.67%

RAW MATERIAL COST(Y)

Fallen by -3.17% (YoY

-9What is not working for the Company
NET SALES(Q)

At CNY 98.8 MM has Fallen at -20.6%

DEBT-EQUITY RATIO (HY)

Highest at -15.44 %

CASH AND EQV(HY)

Lowest at CNY 608.3 MM

Here's what is working for Beijing Balance Medical Technology Co., Ltd.
Net Profit
At CNY 119.62 MM has Grown at 118.1%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (CNY MM)

Net Profit
Higher at CNY 119.62 MM
than preceding 12 month period ended Mar 2025
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (CNY MM)

Operating Cash Flow
Highest at CNY 164.12 MM
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Raw Material Cost
Fallen by -3.17% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Beijing Balance Medical Technology Co., Ltd.
Net Sales
At CNY 98.8 MM has Fallen at -20.6%
over average net sales of the previous four periods of CNY 124.42 MM
MOJO Watch
Near term sales trend is extremely negative

Net Sales (CNY MM)

Debt-Equity Ratio
Highest at -15.44 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Cash and Eqv
Lowest at CNY 608.3 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."